Spinosad Suspension
Product Images NDC 28595-570

13 FDA label images from Allegis Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Spinosad (NDC 28595-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegis Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Spinosad 01)

Chemical Structure (Spinosad 01)
Chemical structure diagram of spinosad, depicting its molecular framework with various rings, oxygen atoms, and methyl groups, consistent with its use as the active ingredient in the topical suspension Spinosad 9 mg/mL.*
FDA Label Image

Chemical Structure (Spinosad 02)

Chemical Structure (Spinosad 02)
Chemical structure of spinosad, the active ingredient in Spinosad topical suspension 9 mg/mL by Allegis Pharmaceuticals, LLC. The diagram shows the molecular arrangement of atoms characteristic of spinosad.*
FDA Label Image

Step 1 (Spinosad 03)

Step 1 (Spinosad 03)
An instructional illustration showing a hand holding a bottle and rotating it up and down along a vertical axis, indicating how to shake or mix the suspension before use.*
FDA Label Image

Step 2 (Spinosad 04)

Step 2 (Spinosad 04)
An instructional illustration showing the application of a topical suspension to a person's scalp. The first panel depicts a hand applying the liquid to the scalp parting the hair, and the second panel shows fingers massaging the product into the scalp with visible hair strands and a bottle nearby.*
FDA Label Image

Step 3 (Spinosad 05)

Step 3 (Spinosad 05)
An instructional illustration showing two steps in eye care. The first panel depicts a person tilting their head backward while administering eye drops, with a note to wait 10 minutes. The second panel shows the person rinsing their eye under running water from a faucet, suggesting eye irrigation or washing after treatment.*
FDA Label Image

Principal Display Panel (120 mL Bottle Carton)

Principal Display Panel (120 mL Bottle Carton)
An instructional diagram showing a hand holding and shaking a small bottle or container. Arrows indicate a vertical up-and-down shaking motion, demonstrating how to properly mix the contents before use.*
FDA Label Image

Spinosad 07

Spinosad 07
An instructional illustration showing a hand applying a liquid topical suspension onto the forearm, indicated by an up-and-down arrow representing the motion of spreading or rubbing the medication on the skin.*
FDA Label Image

Spinosad 08

Spinosad 08
An illustration diagram showing a front and back view of a human figure with a vertical arrow running down from the upper back of the figure in the back view, indicating a measurement or direction related to the back side of the body.*
FDA Label Image

Spinosad 09

Spinosad 09
An illustration showing front and back views of a human body with shaded areas indicating application sites for topical medication: underarms, breasts/chest, elbows, genital area, palms of hands, knees, and soles of feet.*
FDA Label Image

Spinosad 10

Spinosad 10
Illustration showing a human figure alongside a stopwatch icon indicating a 10-minute duration. The image likely relates to the application or usage timing of a product but does not show specific product details.*
FDA Label Image

Spinosad 11

Spinosad 11
Illustration showing a person wearing long-sleeved clothing next to a clock face indicating a time interval of 6 hours, suggesting a time-related instruction or precaution for topical product use.*
FDA Label Image

Spinosad 12

Spinosad 12
An instructional illustration showing a human figure standing under a shower head with water spraying down, suggesting a washing or rinsing action, possibly related to topical product application or removal.*
FDA Label Image

Spinosad 13

Spinosad 13
Packaging label for Spinosad Topical Suspension 0.9% w/w, 120 mL bottle, by Allegis Pharmaceuticals, LLC. The label includes directions, warnings, storage instructions, and ingredients. It states Rx only and emphasizes topical use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.